⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 13, 2003Journal of Clinical Oncology

Lymph Node Dissection: Is It Diagnostic or Therapeutic?

Elin R. Sigurdson

View at Publisher

Ask AI

Bookmark

Share

Abstract

Article Tools EDITORIALS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2003.11.944 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 12637458 Lymph Node Dissection: Is It Diagnostic or Therapeutic? Elin R. SigurdsonxElin R. SigurdsonSearch for articles by this author Show More Fox Chase Cancer Center, Philadelphia, PA https://doi.org/10.1200/JCO.2003.11.944 First Page Full Text PDF Figures and Tables © 2003 by American Society of Clinical Oncology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Elin R. Sigurdson (2003) studied this question.

synapsesocial.com/papers/6aa4d5578cfe0c48ab283b89 https://doi.org/10.1200/jco.2003.11.944

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung CancerOriginal Research · 2003 · 288 citations
2Should Operations Be Regionalized?Original Research · 1979 · 1,759 citations
3Relation of Perioperative Deaths to Hospital Volume Among Patients Undergoing Pancreatic Resection for MalignancyOriginal Research · 1995 · 577 citations
4IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCERPrognostic Study · 2002 · 589 citations
5Prognostic Significance of Axillary Nodal Status in Primary Breast Cancer in Relation to the Number of Resected NodesCohort Study · 1992 · 97 citations

The Will Rogers Phenomenon1985
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation2002
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer2002
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 TrialJournal of Clinical Oncology · 2026
COMPANION-002: A Randomized Phase 2/3 Trial of Tovecimig Plus Paclitaxel versus Paclitaxel Alone as a Second-line Therapy in Patients with Advanced Biliary Tract CancerJournal of Clinical Oncology · 2026

More from Journal of Clinical Oncology